In conjunction with World Chronic Obstructive Pulmonary Disease (COPD) Day, organised by the World Health Organisation and the Global Initiative for Chronic Obstructive Lung Disease (GOLD), a research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has highlighted recent advances in understanding and managing COPD, particularly in relation to its exacerbations. The key findings indicate that patients’ risk profiles can be assessed by measuring blood eosinophil counts at various time points and the isolation of Pseudomonas aeruginosa in sputum, which can facilitate personalised treatment.
